Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TFAP (N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide) is a selective cyclooxygenase-1 (COX-1) inhibitor
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 113.00 | |
25 mg | In stock | $ 218.00 | |
50 mg | In stock | $ 396.00 | |
100 mg | In stock | $ 589.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 76.00 |
Description | TFAP (N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide) is a selective cyclooxygenase-1 (COX-1) inhibitor |
Targets&IC50 | COX-1:0.8 μM |
In vitro | TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor, with an IC50 of 0.8 μM, while that against COX-2 is over 200 μM. |
Synonyms | N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide |
Molecular Weight | 281.23 |
Formula | C13H10F3N3O |
CAS No. | 1011244-68-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 155 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TFAP 1011244-68-0 Immunology/Inflammation Metabolism Neuroscience Endogenous Metabolite COX Cyclooxygenase inhibit Inhibitor N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide inhibitor